Idorsia has partnered with Syneos Health to build a salesforce committed to meeting the therapeutic needs of patients living with Insomnia. Idorsia is a biotech start-up like no other. With a robust pipeline and a world-class R&D engine, Jean-Paul, Chief Executive Officer, and Martine, Chief Scientific Officer, have a vision to build Idorsia into a leading biopharmaceutical company and bring more innovative medicines to patients in need.

This is an exciting time for Idorsia US. Just a few short years after Idorsia’s creation, the US organization is leading the company into a new phase, as we prepare to realize our ambition of bringing innovative medicines from bench to bedside. Idorsia US was established to ensure that patients can benefit from the company’s pioneering therapies. We are building the commercial footprint that will deliver Idorsia’s deep pipeline of products from its R&D engine to the US market – changing the lives of many patients. 

Within this role, you'll contribute to improving the lives of patients while collaborating with a supportive team. Join us in challenging the status quo and work towards getting a much-needed therapy to those who need it most!